METASTATIC PANCREATIC CARCINOMA
Clinical trials for METASTATIC PANCREATIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for pancreatic cancer: targeted drug study goes fully remote
Disease control Recruiting nowThis study tests a drug called pemigatinib in people with advanced or metastatic pancreatic cancer that has certain changes in the FGFR gene. The drug aims to block these abnormal genes and stop tumor growth. About 40 adults will take part entirely from home using telemedicine. T…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: Sameek Roychowdhury • Aim: Disease control
Last updated May 26, 2026 05:40 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests two experimental drugs, ZEN003694 and entinostat, in people with advanced or treatment-resistant solid tumors, including pancreatic cancer. The goal is to find the safest dose and see if the combination can shrink tumors. About 49 participants will take part in t…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:38 UTC
-
Can switching PARP inhibitors outsmart cancer? new trial aims to find out
Disease control Recruiting nowThis study is testing a drug called talazoparib in people with advanced solid tumors that have specific DNA repair gene mutations. The goal is to see if this PARP inhibitor can shrink tumors or slow their growth, even in patients who have already tried a similar drug. About 36 ad…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:32 UTC
-
New hope for hard-to-treat pancreatic cancer: targeted combo enters trial
Disease control Recruiting nowThis study tests a new combination of drugs (HRS-4642, nimotuzumab, and chemotherapy) as a first treatment for 32 people with advanced pancreatic cancer that has a specific KRAS G12D mutation. The goal is to see if this combo can shrink tumors and control the disease. Participant…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Heated chemotherapy shows promise for advanced pancreatic cancer
Disease control Recruiting nowThis study tests a treatment called HIPEC for people with pancreatic cancer that has spread to the lining of the abdomen. HIPEC delivers heated chemotherapy directly into the belly during surgery, aiming to kill cancer cells more effectively. The study will enroll 40 adults aged …
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Scientists use live camera to peek inside tumors during surgery
Knowledge-focused Recruiting nowThis study uses a special microscope called intravital microscopy (IVM) to watch blood vessels inside solid tumors in real time during surgery. Researchers want to see how these vessels work, which could help decide if a patient's tumor is likely to respond to certain treatments.…
Matched conditions: METASTATIC PANCREATIC CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC